Skip to content
Search AI Powered
Human content, AI powered search.

Latest Stories

DH issues supply disruption alert for various oral contraceptive brands

Pb Staff writer
By Pb Staff writerMar 31, 2021
Pb Staff writer
See Full Bio

The Department of Health and Social Care (DH) has issued a medicine supply notification for Oral contraceptive tablets of various brands.

The following oral contraceptive preparations are currently out of stock.

Product affectedIngredientsAnticipated Resupply DateManagement Advice
DianetteEthinylestradiol 35microgram/ Cyproterone 2mg tabletsw/c 26 April 2021Equivalent alternatives remain available from the following manufacturers; Strandhaven Ltd, Stragen UK Ltd and Kent Pharma.
FemodetteEthinylestradiol 20microgram / Gestodene 75microgram tabletsw/c 03 May 2021Equivalent alternatives remain available from suppliers of the following brands: Akizza, Millinette and Sunya
NorgestonLevonorgestrel 30mg tabletsw/c 19 April 2021 – w/c 31 May 2021No exact equivalent available in the UK market. Unlicensed imports have been sourced, lead times vary.
Norinyl-1Mestranol 50microgram / Norethisterone 1mg tabletsw/c 02 August 2021No exact equivalent available in the UK market. Unlicensed imports have been sourced, lead times vary.
QlairaEstradiol Valerate / Dienogest (various strengths)w/c 25 October 2021No exact equivalent available in the UK market.
YiznellEthinylestradiol/drospirenone 30microgram/3mg tabletsw/c 19 April 2021Equivalent alternatives with same composition remain available from suppliers of following brands: Dretine, Yacella,  Ellaite and Lucette.
Yasminw/c 3 May 2021 – w/c 5 July 2021

Target Healthcare and SmartwayPharma have confirmed that it can source unlicensed imports of Mestranol 50 microgram/ Norethisterone 1mg tablets (Norinyl-1 equivalent).

Smartway Pharma has assured that it can source unlicensed imports of Norgeston equivalent Levonorgestrel 30mg tablets.

Smartway has also confirmed that it will source unlicensed imports of various strengths of Estradiol Valerate /Dienogest  to replace Qlaira tablets.

Related News

An estimated shortfall of 16,000 community pharmacists over the next decade, finds CCA report
News

An estimated shortfall of 16,000 community pharmacists over the next decade, finds CCA report

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative
News

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

David Webb
News

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

Community pharmacy has a “vital role to play in rebuilding our NHS” Starmer tells Sigma Conference
News

Community pharmacy has a “vital role to play in rebuilding our NHS” Starmer tells Sigma Conference

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc